Abstract
OnabotulinumtoxinA has recently proved beneficial for the treatment of chronic migraine; even though, headaches are not infrequently reported by patients receiving botulinum toxins for different conditions. Here the author discusses the potential mechanisms on how the immunological response following the application of botulinum toxins may trigger headaches and/or migraine.
Similar content being viewed by others
References
Baizabal-Carvallo JF, Jankovic J, Feld J (2013) Flu-like symptoms and associated immunological response following therapy with botulinum toxins. Neurotox Res 24:298–306
Bø SH, Davidsen EM, Gulbrandsen P et al (2009) Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia 29:365–372
Diener HC, Dodick DW, Turkel CC et al (2014) Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine. Eur J Neurol 21:851–859
Neeb L, Hellen P, Boehnke C et al (2011) IL-1β stimulates COX-2 dependent PGE2 synthesis and CGRP release in rat trigeminal ganglia cells. PLoS ONE 6:e17360
Perini F, D’Andrea G, Galloni E et al (2005) Plasma cytokine levels in migraineurs and controls. Headache 45:926–931
Zhang X, Burstein R, Levy D (2012) Local action of the proinflammatory cytokines IL-1β and IL-6 on intracranial meningeal nociceptors. Cephalalgia 32:66–72
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baizabal-Carvallo, J.F. Can the Immunological Response to Botulinum Toxin Trigger Headaches?. Neurotox Res 27, 69–70 (2015). https://doi.org/10.1007/s12640-014-9490-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-014-9490-z